#Oncology Research Innovation and Impact Awards
Explore tagged Tumblr posts
Visit Tumblr Blog
Explore Tumblr blogs with no restrictions, modern design and the best experience.
Last Seen Tumblr Blogs
Fun Fact
BuzzFeed published a report claiming that Tumblr was utilized as a distribution channel for Russian agents to influence American voting habits during the 2016 presidential election in Feb 2018.
Text
youtube
#International Research Awards on Oncology and Cancer Research#Cancer Research Awards#Oncology Research Recognition#Global Oncology Awards#Oncology and Cancer Research Excellence#Cancer Research Innovation Awards#Awards for Cancer Therapy Research#Oncology Researcher Recognition#Cancer Research Impact Awards#Oncology Scientist of the Year#Breakthroughs in Cancer Research Awards#Excellence in Oncology Awards#International Oncology Research Achievements#Cancer Treatment and Research Awards#Global Oncology Research Contributions#Oncology Research Innovation and Impact Awards#Advances in Cancer Research Awards#Oncology Clinical Research Excellence#Cancer Biology Research Awards#Translational Cancer Research Awards.#Youtube
0 notes
Text
A Comprehensive Overview of Life Science Tools Market Landscape
The global life science tools market size is expected to reach USD 330.69 billion by 2030, according to a new report by Grand View Research, Inc., expanding at a CAGR of 10.8% from 2023 to 2030. This growth can be attributed to a rise in government funding for life science technologies, demand for cell and gene therapies, an increase in the adoption of biopharmaceuticals, and growing competition among prominent companies in the market.
The exponential rise of COVID-19 cases globally requires rapid diagnosis for containment of the spread of infectious disease, which boosted the demand for life science tools during the pandemic and had a positive impact on the market. Rapid diagnosis of the infection, effective treatments, and preventative plans are essential for the management of cases during the COVID-19 pandemic. The current race for the development of cost-effective point-of-contact test kits and efficient laboratory methodologies for confirmation of SARS-CoV-2 infection has driven a new frontier of diagnostic innovation. During this pandemic, the U.S. FDA granted Emergency Use Authorizations (EUAs) to several diagnostic tests to make them rapidly and easily available for use. For example, in May 2022, the U.S. FDA granted a EUA to ID NOW COVID-19 2.0, a rapid in-vitro diagnostic test by Abbott Diagnostics Scarborough, Inc. Moreover, a wide range of commercial COVID-19 tests is available in the marketplace, which will further add to revenue generation.
Additionally, the life science tools industry is expanding based on the increasing investments by the government for the advancement of research and technologies. Organizations such as The National Human Genome Research Institute (NHGRI) and the National Institutes of Health (NIH) are actively funding various life science projects. For instance, the NIH funded USD 25 million for the ‘4D Nucleome Program’, which aims to understand gene regulation and cellular expression via the nuclear organization. Moreover, the U.S. government has funded several life sciences companies for R&D purposes. For instance, the Biomedical Advanced Research and Development Authority (BARDA) has planned to make awards worth USD 750,000 to facilitate the development of innovative technologies in the healthcare sector. Thus, the increase in government funding for life science research as well as technologies is expected to drive the market in the coming years.
Gather more insights about the market drivers, restrains and growth of the Life Science Tools Market
Life Science Tools Market Report Highlights
• By technology, cell biology technology accounted for the largest share in 2022. The introduction of novel technologies for the usage and adoption of stem cells, CAR T-cells, TCR T-cells, NK T-cells, and other cell therapies is expected to boost revenue generation in this segment
• By product, the cell culture systems and 3D cell culture segment held the largest share in 2022. Cell biology is gaining popularity across multiple aspects in the life science industry, which is contributing significantly to the revenue generated by this segment
• By end-use, the healthcare segment generated the highest revenue in 2022. The rise in adoption of proteomic and genomic workflows in clinics, hospitals, and diagnostic laboratories for the treatment and diagnosis of several clinically presented abnormalities is anticipated to drive the market
• North America accounted for the largest revenue share in 2022. The rapid adoption of genomics, proteomics, oncology, and diagnostic screening in the region has contributed to regional growth. In addition, a number of major market players are continuously engaged in the development of advanced tools for life science research in this region
• Asia Pacific is expected to grow at the highest rate over the projected period. Investments by global companies in this region to utilize the untapped avenue and lucrative opportunities will drive the regional market
Life Science Tools Market Segmentation
Grand View Research has segmented the global life science tools market on the basis of technology, product, end-use, and region:
Life Science Tools Technology Outlook (Revenue, USD Billion, 2018 - 2030)
• Genomic Technology
• Proteomics Technology
• Cell Biology Technology
• Other Analytical & Sample Preparation Technology
• Lab Supplies & Technologies
Life Science Tools Product Outlook (Revenue, USD Billion, 2018 - 2030)
• Cell Culture Systems & 3D Cell Culture
o Instruments
o Consumables
o Cell & Tissue Culture Services
• Liquid Chromatography
o Instruments
o Consumables
o Services
• Mass Spectrometry
o Instruments
o Consumables
o Services
• Flow Cytometry
o Instruments
o Consumables
o Services
• Cloning & Genome Engineering
o Kits, Reagents, and Consumables
o Services
• Microscopy & Electron Microscopy
o Instruments
o Consumables
o Services
• Next Generation Sequencing
o Instruments
o Consumables
o Services
• PCR & qPCR
o Instruments
o Consumables
o Services
• Nucleic Acid Preparation
o Instruments
o Consumables
o Services
• Nucleic Acid Microarray
o Instruments
o Consumables
o Services
• Sanger Sequencing
o Instruments
o Consumables
o Services
• Transfection Devices & Gene Delivery Technologies
o Equipment
o Reagents
• NMR
o Instruments
o Consumables
o Services
• Other Separation Technologies
o Instruments
o Consumables
o Services
• Other Products & Services
o Antibodies
o General Supplies
o Others
Life Science Tools End-use Outlook (Revenue, USD Billion, 2018 - 2030)
• Government & Academic
• Biopharmaceutical Company
• Healthcare
• Industrial Applications
• Others
Life Science Tools Regional Outlook (Revenue, USD Billion, 2018 - 2030)
• North America
o U.S.
o Canada
• Europe
o UK
o Germany
o France
o Italy
o Spain
o Denmark
o Sweden
o Norway
o Switzerland
• Asia Pacific
o Japan
o China
o India
o Australia
o Thailand
o South Korea
o Singapore
• Latin America
o Brazil
o Mexico
o Argentina
• Middle East & Africa
o South Africa
o Saudi Arabia
o UAE
o Kuwait
Order a free sample PDF of the Life Science Tools Market Intelligence Study, published by Grand View Research.
#Life Science Tools Market#Life Science Tools Market Size#Life Science Tools Market Share#Life Science Tools Market Analysis#Life Science Tools Market Growth
0 notes
Text
How to Achieve a Healthy Lifestyle with Simple Daily Habits
Dr. Amit Bhushan has emerged as a prominent name in the field of modern medicine, renowned for his innovative approaches, extensive expertise, and unwavering commitment to patient care. With an impressive career spanning decades, Dr. Amit Bhushan's has set a benchmark for excellence in the medical community. This blog delves into his achievements, contributions, and the qualities that make him a distinguished professional in his field.
A Journey of Excellence in Medicine
Dr. Amit Bhushan's journey in the medical field began with a strong academic foundation. Having graduated with top honors from a reputed medical college, he pursued advanced training in specialized areas, earning accolades for his dedication and proficiency. His relentless pursuit of knowledge has led him to become a master in his domain, ensuring that his patients receive the best possible care backed by the latest scientific advancements.
Specialization and Expertise
Dr. Amit Bhushan is celebrated for his expertise in [specific specialization, e.g., cardiology, neurology, or oncology]. His ability to diagnose and treat complex medical conditions has earned him the trust and admiration of patients and peers alike. Through his practice, Dr. Amit Bhushan has handled a wide range of cases, from routine consultations to life-saving surgeries, demonstrating his versatility and precision in the field.
Innovative Medical Techniques
Innovation has been a hallmark of Dr. Amit Bhushan's career. By adopting cutting-edge technologies and implementing advanced treatment protocols, he has consistently stayed ahead of the curve. Whether it's the integration of minimally invasive surgical techniques or personalized patient care plans, Dr. Amit Bhushan's approach is both progressive and patient-centric. His ability to merge innovation with empathy has set a new standard in healthcare delivery.
A Commitment to Patient Care
Dr. Amit Bhushan's philosophy revolves around putting patients first. He believes in building strong doctor-patient relationships based on trust, transparency, and compassion. His approachable demeanor and attentive listening make patients feel valued and understood, creating a positive and supportive healing environment. This dedication to patient welfare is a cornerstone of his practice, distinguishing him from his contemporaries.
Contributions to the Medical Community
Beyond his clinical practice, Dr. Amit Bhushan is actively involved in contributing to the broader medical community. He regularly participates in international conferences, sharing his insights and learning from global experts. Additionally, he has authored numerous research papers in esteemed medical journals, furthering the understanding of complex medical conditions and their treatments.
Recognition and Awards
Dr. Amit Bhushan's achievements have not gone unnoticed. Over the years, he has received several prestigious awards, recognizing his contributions to medicine and healthcare. These accolades are a testament to his unwavering dedication and the impact he has made in the lives of countless patients.
Empowering the Next Generation
As a mentor and educator, Dr. Amit Bhushan is committed to shaping the future of medicine. He takes pride in training budding medical professionals, equipping them with the knowledge and skills necessary to excel in their careers. His mentorship has inspired many young doctors to pursue excellence and uphold the highest standards of patient care.
Conclusion
Dr. Amit Bhushan's remarkable journey is a testament to his passion for medicine, his dedication to innovation, and his commitment to improving lives. As a pioneer in his field, he continues to set new benchmarks, inspiring patients and medical professionals alike.
Whether you're seeking expert care or looking for inspiration in the field of medicine, Dr. Amit Bhushan remains a beacon of excellence and compassion in the ever-evolving world of healthcare.
0 notes
Text
Regional Breakdown of the PET Market Size
The Positron Emission Tomography (PET) Market size was estimated at USD 2.6 billion in 2023 and is expected to reach USD 4.30 billion by 2031 with a growing CAGR of 5.9% during the forecast period of 2024-2031.The Positron Emission Tomography (PET) market is a dynamic landscape at the intersection of cutting-edge medical technology and diagnostics. As demand grows for precise, non-invasive imaging techniques in healthcare, PET stands out for its ability to provide detailed insights into metabolic processes at the molecular level.
Advancements in radiopharmaceuticals and imaging hardware continue to drive innovation, enhancing PET's diagnostic accuracy and expanding its applications across oncology, neurology, and cardiology. With increasing investments in research and development, coupled with rising healthcare expenditure globally, the PET market is poised for significant growth, promising improved patient outcomes through early detection and personalized treatment strategies.
Get Sample Of This Report @ https://www.snsinsider.com/sample-request/3443
Segmentation View
By Product
PET/CT Systems
Low Slice Scanners
Medium Slice Scanners
High Slice Scanners
PET/MRI Systems
By Application
Oncology Applications
Neurological Applications
Cardiovascular Applications
Other Applications
By End User
Hospital & Surgical Centers
Diagnostic & Imaging Clinics
Ambulatory Care Centers
Other End Users
Russia-Ukraine War Impact on Positron Emission Tomography Market
The analysis also contains significant data on the actual impacts of the conflict between Russia and Ukraine on the world market. The essay goes into great detail about a variety of global regions and how the war has affected their economies.
Competitive Scenario
This research gave readers a realistic image of the sector by outlining the full competitive landscape and the key providers' commodities supply, which was scattered across a wide range of geographical areas. For the forecast period, the paper provides the most recent market forecast analyses. To help enterprises comprehend the competitive climate of the top global suppliers of Positron Emission Tomography Market , the study provides an in-depth analysis of industry competition as well as a synopsis of Porter's Five Forces model.
Report Conclusion
The Positron Emission Tomography Market research study covers four levels of depth, including supply chain analysis, top-level firm market share analysis, business analysis (industry trends), and brief sector profiles, to name a few. The key ideas of the business environment, high-growth markets, high-growth countries, significant industry differences, business variables, and restrictions are also covered in this study.
About Us
SNS Insider is a market research and insights firm that has won several awards and earned a solid reputation for service and strategy. We are a strategic partner who can assist you in reframing issues and generating answers to the trickiest business difficulties. For greater consumer insight and client experiences, we leverage the power of experience and people.
When you employ our services, you will collaborate with qualified and experienced staff. We believe it is crucial to collaborate with our clients to ensure that each project is customized to meet their demands. Nobody knows your customers or community better than you do. Therefore, our team needs to ask the correct questions that appeal to your audience in order to collect the best information.
Related Reports
Glaucoma Therapeutics Market Analysis
AI in Cancer Diagnosis Market Analysis
Blood Group Typing Market Analysis
DNA Synthesis Market Analysis
Genomics Services Market Analysis
0 notes
Text
Unveiling the Innovations: Leading Anticancer Drug Manufacturers in India
In the landscape of anticancer drug manufacturing in India, stands as a leading player, housing a cluster of innovative companies that are revolutionizing the fight against cancer. Among these pioneering manufacturers, Florencia Healthcare has emerged as a prominent name, contributing significantly to this global battle. With a commitment to excellence and a strong focus on technology-driven research and development, Florencia Healthcare has been instrumental in equipping healthcare professionals with a diverse range of anticancer drugs that adhere to international quality standards.
Florencia Healthcare's dedication to patient-centric care and its continuous quest for breakthrough solutions have earned it a reputation as a trusted partner in the oncology community. By harnessing the power of advanced technologies and strategic collaborations, Florencia Healthcare is shaping the future of anticancer drug manufacturing in India, ultimately driving positive patient outcomes across the globe. As a leading pioneer in the field, Florencia Healthcare embraces innovation, compassion, and a relentless pursuit of medical advancements, ensuring that individuals affected by cancer receive the best possible care.
Importance of Anticancer Drug Manufacturers in India
India, with its vast population and rising cancer incidence, has a critical need for high-quality, affordable anticancer drugs. The country's pharmaceutical industry plays a pivotal role in meeting this demand and improving patient outcomes. Anticancer drug manufacturers in India contribute significantly to global healthcare by providing access to life-saving medications at competitive prices. These manufacturers not only cater to the domestic market but also export their products to various countries, thereby contributing to the global fight against cancer.
Overview of the Indian Pharmaceutical Industry
The Indian pharmaceutical industry is one of the largest and fastest-growing sectors in the country. Known for its cost-effective generic drugs, India has become a global hub for pharmaceutical manufacturing. The industry encompasses a wide range of companies, from small-scale manufacturers to large multinational corporations. With a robust regulatory framework and a strong emphasis on research and development, the Indian pharmaceutical industry has gained recognition for its quality standards and technological advancements.
Leading Anticancer Drug Manufacturers in India
Several pharmaceutical companies in India have made significant contributions to the field of anticancer drug manufacturing. These companies possess state-of-the-art infrastructure, cutting-edge research facilities, and a team of highly skilled scientists and healthcare professionals. Alongside Florencia Healthcare, other leading manufacturers in India include:
Florencia Healthcare- Commitment to excellence has been recognized through various industry awards and accolades, further solidifying its position as a leading manufacturer in the Indian pharmaceutical landscape.
Biocon Limited - A pioneer in biotechnology-based anticancer drugs, Biocon is known for its innovative therapies and commitment to affordability.
Dr. Reddy's Laboratories - With a strong global presence, Dr. Reddy's Laboratories specializes in developing and manufacturing a wide range of generic anticancer medications.
Sun Pharmaceutical Industries - Sun Pharma focuses on research and development of novel drug delivery systems and has a diverse portfolio of anticancer drugs.
Cipla Limited - Cipla has been at the forefront of providing affordable cancer treatments, making a significant impact on the accessibility of anticancer drugs in India and beyond.
History and Achievements of Florencia Healthcare
Florencia Healthcare, founded in 2011, has a rich history of pioneering research and development in the field of anticancer drugs. The company has consistently strived to deliver superior-quality medications that meet the highest international standards. Florencia Healthcare's commitment to excellence has been recognized through various industry awards and accolades, further solidifying its position as a leading manufacturer in the Indian pharmaceutical landscape.
Innovative Approaches in Anticancer Drug Manufacturing
Innovation is the cornerstone of the success of Florencia Healthcare and other leading oncology drug manufacturers and suppliers in India. These companies invest heavily in research and development to develop novel therapies, improve drug delivery systems, and enhance treatment outcomes. By leveraging advanced technologies such as artificial intelligence, machine learning, and genomics, these manufacturers can identify new drug targets, optimize drug formulations, and personalize treatment approaches for cancer patients.
Quality Standards and Certifications in the Pharmaceutical Industry
Maintaining stringent quality standards is of paramount importance in the pharmaceutical industry, especially when it comes to manufacturing anticancer drugs. Leading manufacturers like Florencia Healthcare adhere to internationally recognized quality management systems and certifications. These certifications, such as ISO 9001:2008, and Good Manufacturing Practice (GMP), ensure that the manufacturing processes are robust, efficient, and compliant with regulatory requirements. By adhering to these standards, manufacturers can guarantee the safety, efficacy, and reliability of their anticancer drugs.
The Role of Government Regulations in Drug Manufacturing
The Indian pharmaceutical industry operates under the guidance of various government regulations and regulatory bodies. The Central Drugs Standard Control Organization (CDSCO) is responsible for approving and monitoring the manufacturing, marketing, and distribution of drugs in India. These regulations ensure that the anticancer drugs produced by manufacturers like Florencia Healthcare meet the highest standards of safety, efficacy, and quality. Government support and favorable policies also play a crucial role in fostering innovation and enabling manufacturers to bring affordable anticancer drugs to market.
Challenges and Future Prospects for Anticancer Drug Manufacturers in India
While the Indian pharmaceutical industry has made significant strides in anticancer drug manufacturing, it faces several challenges. These include the increasing complexity of cancer therapies, rising research and development costs, and the need for continuous innovation. Additionally, the industry must navigate complex regulatory pathways and address the affordability and accessibility of anticancer drugs for all segments of society. However, with a strong focus on research, development, and strategic collaborations, manufacturers like Florencia Healthcare are well-positioned to overcome these challenges and drive the future of anticancer drug manufacturing in India.
Conclusion and the Impact of Florencia Healthcare on the Indian Pharmaceutical Industry
Florencia Healthcare, along with other leading anticancer drug manufacturers and exporters in India, has played a crucial role in shaping the landscape of cancer treatment. Through their commitment to innovation, adherence to quality standards, and patient-centric approach, these manufacturers have made a significant impact on the lives of cancer patients in India and around the world. Florencia Healthcare's dedication to excellence and continuous pursuit of breakthrough solutions position it as a trusted partner in the fight against cancer. As the Indian pharmaceutical industry continues to evolve, the contributions of manufacturers like Florencia Healthcare will undoubtedly drive positive change and transform the future of anticancer drug manufacturing.
Frequently Asked Questions (FAQs)
1. What role do anticancer drug manufacturers in India play in the global fight against cancer?
Anticancer drug manufacturers in India contribute significantly to global healthcare by providing access to high-quality and affordable medications. They cater to the domestic market and also export their products to various countries, thereby aiding the global fight against cancer.
2. What are some leading anticancer drug manufacturers in India apart from Florencia Healthcare?
Apart from Florencia Healthcare, other leading anticancer drug manufacturers in India include Biocon Limited, Dr. Reddy's Laboratories, Sun Pharmaceutical Industries, and Cipla Limited. These companies are known for their innovative therapies, commitment to affordability, and global presence.
3. What are some of the innovative approaches employed by Indian anticancer drug manufacturers in drug manufacturing?
Indian anticancer drug manufacturers employ innovative approaches such as advanced technologies like artificial intelligence, machine learning, and genomics. These technologies help in identifying new drug targets, optimizing drug formulations, and personalizing treatment approaches for cancer patients.
4. How do anticancer drug manufacturers ensure the quality and safety of their medications?
Leading manufacturers adhere to internationally recognized quality management systems and certifications such as ISO 9001, ISO 13485, and Good Manufacturing Practice (GMP). These certifications ensure that manufacturing processes are robust, efficient, and compliant with regulatory requirements, guaranteeing the safety, efficacy, and reliability of anticancer drugs.
5. What are some challenges faced by anticancer drug manufacturers in India, and how are they addressing them?
Challenges faced by anticancer drug manufacturers in India include the increasing complexity of cancer therapies, rising research and development costs, and the need for continuous innovation. To address these challenges, manufacturers focus on research, development, and strategic collaborations to drive positive change and transform the future of anticancer drug manufacturing.
6. How do government regulations influence drug manufacturing in India?
The Indian pharmaceutical industry operates under the guidance of various government regulations and regulatory bodies, such as the Central Drugs Standard Control Organization (CDSCO). These regulations ensure that drugs, including anticancer medications, meet the highest standards of safety, efficacy, and quality. Government support and favorable policies also foster innovation and enable manufacturers to bring affordable drugs to market.
7. What impact has Florencia Healthcare had on the Indian pharmaceutical industry?
Florencia Healthcare, along with other leading anticancer drug manufacturers in India, has played a crucial role in shaping the landscape of cancer treatment. Through their commitment to innovation, adherence to quality standards, and patient-centric approach, these manufacturers have made a significant impact on the lives of cancer patients in India and around the world. Florencia Healthcare's dedication to excellence and continuous pursuit of breakthrough solutions position it as a trusted partner in the fight against cancer.
#anticancer medicine#anticancer drugs#anticancer drugs manufacturer#anticancer medicine exporter#anticancer medicine supplier#anticancer drugs supplier#oncology drugs manufacturers in india#oncology medicine manufacturers in india
0 notes
Text
Dr. Ashok Kumar Vaid | Best Oncologist in India
Dr. Ashok Kumar Vaid stands as a beacon of excellence in the field of oncology at Medanta Gurgaon, where he has garnered a reputation as the go-to expert for the treatment of organ-specific cancers, leukemias, and lymphomas. With a distinguished career spanning several decades, Dr. Vaid's journey to becoming one of India's leading oncologists is marked by remarkable achievements and contributions to the medical field.
Educational Background and Training
Dr. Vaid's academic journey commenced with an MBBS degree from Jammu University in 1984, laying the foundation for his illustrious career in medicine. He further honed his expertise by completing DNB in internal medicine and DM Medical Oncology in 1993. During his senior residency at Govt. Medical College, Jammu, from 1987 to 1989, he gained invaluable experience that would shape his future endeavors in oncology.
Professional Experience and Accolades
Prior to joining Medanta Gurgaon, Dr. Vaid served as the Head of the Department of Medical Oncology at Artemis Health Institute, Gurgaon, where he made significant strides in advancing cancer treatment. His exemplary contributions to the field of medicine were recognized with the prestigious Padma Shri award in 2009, a testament to his dedication and expertise.
Membership and Contributions
Dr. Vaid's commitment to advancing oncology extends beyond his clinical practice. He is actively involved in various prestigious organizations, including the Breast Cancer Foundation of India, Indian Society of Medical & Pediatric Oncology, and Indian Association of Gynaec Oncologists, among others. As a founder member of the Indian Cooperative Oncology Network (ICON), he has played a pivotal role in shaping the landscape of oncology research and treatment in India.
Pioneering Achievements
Dr. Vaid's pioneering spirit is evident in his groundbreaking work in bone marrow transplantation. He holds the unique distinction of having conducted the first 25 bone marrow transplants in any private sector hospital in North India, underscoring his commitment to pushing the boundaries of medical innovation.
Research and Publications
Dr. Vaid's contributions to oncology research are extensive, with numerous papers and clinical research published in prestigious national and international medical journals. His work has not only enriched the scientific community but has also had a profound impact on cancer treatment protocols both within India and globally.
Legacy of Excellence
Dr. Ashok Kumar Vaid's legacy as a trailblazer in oncology continues to inspire generations of medical professionals. His unwavering dedication to patient care, coupled with his relentless pursuit of medical advancement, cements his status as one of the finest oncologists in the country. Under his leadership, Medanta Gurgaon remains at the forefront of cancer treatment, providing hope and healing to countless patients battling this formidable disease.
0 notes
Text
A Beacon of Care - Dr. Suyash Agrawal's Impact as the Best Cancer Specialist in Indore
Introduction - Best Cancer Specialist in Indore
In the bustling city of Indore, under the various hurdles of cancer treatment, Dr. Suyash Agrawal serves as a beacon of hope and care for multiple people. Dr. Agrawal is widely regarded as the Best Cancer Specialist In Indore due to his constant attention to his patients and his innovative approach to oncology.
Early Years and Education
Born and raised in Indore, Dr. Suyash Agrawal's journey towards becoming a leading cancer specialist began with a passion for science and a drive to make a difference in the lives of others. His academic prowess led him to pursue a degree in medicine, where he exhibited exceptional dedication and commitment to his studies.
Book An Appointment - https://maps.app.goo.gl/j9UdzMKntyR4mkyMA
Specialization in Oncology
Driven by a desire to confront one of the most formidable diseases plaguing humanity, Dr. Agrawal chose to specialize in oncology early in his career. Witnessing the immense suffering of cancer patients and their families fueled his determination to alleviate their pain and offer them a glimmer of hope in their darkest hours.
Establishing Practice in Indore
After completing his medical training and gaining invaluable experience in renowned healthcare institutions, Dr. Suyash Agrawal returned to his hometown of Indore to establish his practice. Despite facing initial challenges in setting up his clinic, his passion for serving his community and his unwavering commitment to excellence propelled him forward.
Book An Appointment - https://maps.app.goo.gl/j9UdzMKntyR4mkyMA
Philosophy of Care
At the heart of Dr. Agrawal's practice lies a profound philosophy of care that places the patient at the center of every decision and treatment plan. He believes in providing not just medical treatment, but also emotional support and compassionate care to every individual under his guidance.
State-of-the-Art Facilities
Recognizing the importance of access to cutting-edge technology in cancer treatment, Dr. Agrawal has equipped his clinic with state-of-the-art facilities. From advanced diagnostic tools to innovative treatment modalities, every aspect of his practice reflects his commitment to offering the best possible care to his patients.
Community Outreach and Awareness
Beyond the confines of his clinic, Dr. Suyash Agrawal actively engages in community outreach programs to raise awareness about cancer prevention and early detection. Through educational initiatives and public seminars, he empowers individuals to take control of their health and seek timely medical intervention when needed.
Patient Testimonials
The impact of Dr. Agrawal's compassionate care and expertise is best reflected in the stories of his patients. Countless individuals have emerged from their battles with cancer, not only healed physically but also uplifted by Dr. Agrawal's unwavering support and encouragement.
Recognition and Awards
Dr. Agrawal's exemplary contributions to the field of oncology have garnered him numerous accolades and awards. His peers and patients alike have recognized his dedication, skill, and compassion, further solidifying his reputation as the Best Cancer Specialist In Indore.
Research and Innovations
In addition to his clinical practice, Dr. Agrawal is actively involved in research aimed at advancing the field of oncology. His innovative approaches to treatment and his commitment to staying abreast of the latest developments in cancer care ensure that his patients receive the most effective and cutting-edge therapies available.
Collaborations and Partnerships
Recognizing the importance of collaboration in tackling the complex challenges posed by cancer, Dr. Agrawal actively collaborates with other healthcare institutions and professionals. By pooling resources and expertise, he seeks to enhance the quality of cancer care available in Indore and beyond.
Book An Appointment - https://maps.app.goo.gl/j9UdzMKntyR4mkyMA
Impact on the Community
Dr. Suyash Agrawal's impact extends far beyond the walls of his clinic, shaping the very fabric of the community he serves. Through his compassionate care, tireless advocacy, and unwavering commitment to excellence, he has touched the lives of countless individuals and families, offering them hope, healing, and support in their time of need.
Future Goals
Looking ahead, Dr. Agrawal remains steadfast in his commitment to advancing cancer care and improving outcomes for his patients. His vision for the future encompasses not only medical excellence but also greater access to care, enhanced support services, and a continued focus on preventive efforts to combat cancer.
Conclusion
In conclusion, Dr. Suyash Agrawal's journey from humble beginnings to becoming the Best Cancer Specialist In Indore is a testament to his unwavering dedication, compassion, and commitment to excellence. Through his tireless efforts, he has emerged as a beacon of care and hope for all those affected by cancer, embodying the very essence of medical professionalism and humanity.
FAQs
What sets Dr. Suyash Agrawal apart as the best cancer specialist in Indore?
Dr. Agrawal's unparalleled commitment to patient care, combined with his expertise and compassion, distinguishes him as a leading figure in the field of oncology in Indore.
Does Dr. Agrawal offer personalized treatment plans for his patients?
Yes, Dr. Agrawal believes in tailoring treatment plans to meet the individual needs and preferences of each patient, ensuring the best possible outcomes.
How can I schedule a consultation with Dr. Suyash Agrawal?
To schedule a consultation with Dr. Suyash Agrawal, you can contact his clinic directly through their website or by calling their office. The staff is dedicated to assisting patients and ensuring that appointments are scheduled promptly to address their needs.
Book An Appointment - https://maps.app.goo.gl/j9UdzMKntyR4mkyMA
Does Dr. Agrawal accept insurance for his services?
Yes, Dr. Agrawal's clinic accepts a variety of insurance plans to facilitate access to care for patients. It's recommended to verify coverage with your insurance provider before your appointment.
What should I expect during my first visit to Dr. Agrawal's clinic?
During your initial consultation, Dr. Agrawal will conduct a comprehensive evaluation of your medical history, perform necessary diagnostic tests, and discuss treatment options tailored to your specific condition and needs.
Can Dr. Agrawal provide support for patients undergoing cancer treatment?
Dr. Agrawal and his team offer comprehensive support services to help patients navigate their cancer journey, including emotional support, nutritional guidance, and access to additional resources and specialists as needed.
Conclusion
In summary, Dr. Suyash Agrawal's impact as the Best Cancer Specialist In Indore transcends mere medical expertise; it is a testament to his unwavering dedication, compassion, and commitment to excellence. Through his pioneering approach to oncology, state-of-the-art facilities, and compassionate care, Dr. Agrawal has touched the lives of countless individuals and families, offering them hope, healing, and support in their time of need. As he continues to forge ahead in his mission to combat cancer and improve outcomes for his patients, Dr. Agrawal remains a shining example of medical professionalism and humanity.
Book An Appointment - https://maps.app.goo.gl/j9UdzMKntyR4mkyMA
Follow Us On : Facebook | Instagram | Twitter | LinkedIn | Pinterest | Google My Business | YouTube
1 note
·
View note
Text
Why Nurses Are More Important Than Doctors
Within the complex field of healthcare, physicians frequently receive a lot of attention, but nurses also play a critical role in patient care while working quietly in the background. A paradigm change has occurred in recent years, acknowledging the invaluable contribution that nurses provide to the healthcare system.
Nurses go beyond administering medications. They provide holistic care, offering emotional support and acting as advocates for patients. In times of vulnerability, it is often the reassuring presence of a nurse that makes a significant difference.
Rigorous training molds nurses into versatile professionals. Their commitment to continuous learning ensures they stay abreast of the latest medical advancements, contributing to better patient outcomes.
Versatility in Specializations
From critical care to community health, nurses wear many hats. Their ability to adapt to various settings makes them indispensable members of the healthcare team.
Patient Interaction
Unlike doctors who may have time constraints, nurses spend more time with patients. This allows for the development of strong connections, fostering a sense of trust and comfort.
Advancements in technology have reshaped the nursing landscape. Nurses embrace these changes, enhancing their efficiency and the overall quality of patient care.
Collaborative Healthcare
Effective teamwork is the cornerstone of successful healthcare. The symbiotic relationship between doctors and nurses ensures a comprehensive approach to medical care.
Despite their crucial role, nurses often face challenges like underappreciation and burnout. Addressing these issues is essential for sustaining a resilient healthcare workforce.
Impact on Patient Outcomes
Studies show that nursing care directly influences patient recovery. A holistic approach to healthcare, where nurses play a central role, leads to improved outcomes.
Public Perception and Misconceptions
Changing societal perspectives and dispelling stereotypes are crucial. Understanding the true extent of a nurse’s responsibilities contributes to a more informed public.
Recognizing Nurses’ Achievements
Acknowledging the achievements of nurses is essential for morale. Awards and celebrations of success stories create a positive and motivating work environment.
Future of Nursing
The nursing profession is evolving, offering various career advancements. Embracing technological changes ensures that nurses stay at the forefront of healthcare innovation.
Nurses in Global Healthcare
Beyond national borders, nurses contribute significantly to global health. Their role in bridging healthcare gaps worldwide is vital for creating a healthier planet.
Call to Action
Recognizing the vital role of nurses is not just a responsibility but a necessity. It’s time to appreciate, support, and advocate for the unsung heroes of healthcare.
Conclusion
In the grand symphony of healthcare, nurses are the unsung melody, weaving through the complexities with grace and precision. Their importance cannot be overstated, and it’s high time we acknowledge the vital role they play in shaping the landscape of global health.
FAQs
Are nurses as educated as doctors?
Nurses undergo rigorous training and education, often specializing in specific areas, making them highly knowledgeable in their respective fields.
2. Do nurses only work in hospitals?
No, nurses work in various settings, including community health, schools, research institutions, and more, showcasing their versatility.
3. How do nurses handle stress and burnout ?
Coping mechanisms and support systems are in place, including counseling services and initiatives to promote a healthy work-life balance.
4. Can nurses specialize in a particular medical field ?
Yes, nurses can specialize in various fields such as critical care, pediatrics, oncology, and more, allowing them to focus on areas they are passionate about.
5. What advancements are expected in the nursing profession ?
The future of nursing involves embracing technology, with innovations like telehealth and AI playing a significant role in enhancing patient care.
reed more…… taskarmall.com
#NursingHeroes#HealthcareProfessionals#NurseAdvocacy#PatientCare#NurseVersatility#MedicalTeamwork#NursingInnovation#GlobalHealthNurses#RecognizeNurses#NurseAppreciation#HolisticHealthcare
0 notes
Text
PCRF Funding Supports Research to Reduce Childhood Cancer
The Pediatric Cancer Research Foundation (PCRF) is dedicated to eradicating childhood cancer by accelerating scientific breakthroughs that lead to cures. Since its inception in 1982, PCRF has continuously worked toward its mission of ensuring that no child succumbs to cancer.
PCRF focuses on funding revolutionary research aimed at developing less toxic cancer treatment regimens. The foundation strives to empower researchers across the nation whose innovative ideas hold the potential to revolutionize pediatric cancer care. Having invested over $58 million in pediatric cancer research, PCRF has significantly contributed to transformative advances in cancer treatment.
By providing crucial early-stage funding, PCRF enables researchers to prove their concepts, laying a foundation for larger grants and federal funding. This approach has propelled the cultivation of a new generation of researchers, reshaping the landscape of pediatric cancer treatment and diagnosis.
The foundation efficiently channels donated funds into impactful research endeavors within a year of receipt. Following a stringent evaluation by a panel of independent scientists and subject-matter experts, it allocates donations to pioneering projects with the potential to bring about significant breakthroughs. Grant awards are finalized and distributed to researchers during the initial quarter of the subsequent year.
Although the research grant process is straightforward, the research journey itself is complex. From the point of discovery to realizing FDA-approved treatments, scientific achievements can take from several months to decades to benefit patients. Within a rigorous research process, increased funding enables the simultaneous testing of numerous innovative concepts, with the primary aim of expediting the transition of discoveries from the laboratory to enhanced patient care. Every donation directly works toward cures and promising futures for children.
Donations made to PCRF have been pivotal in the organization’s ability to fund remarkable progress. This funding has been directly used to support research on pioneering treatments for various types of childhood cancers.
One notable milestone is the pivotal role PCRF-funded research played in curing advanced mature B cell non-Hodgkin lymphoma in children and adolescents. Through innovative therapies, toxic exposure and treatment periods have been reduced. More efficient treatment strategies enable young patients to lead healthier lives and spend less time in hospitals while undergoing therapy.
PCRF's allocation of funding for research on CART cell infusion facilitated groundbreaking treatment approaches. The development of T cells paired with genetic engineering led to the first-in-human protocol targeting leukemia. This revolutionary work paved the way for state of the art therapies harnessing the body’s immune system, driving advances in immuno-oncology.
Funding from PCRF has demonstrated the potential of immunotherapy in treating osteosarcoma, a form of bone cancer that initially develops in the cells that produce bones. This research offers hope for patients who previously had limited treatment options.
PCRF funding has also enabled diagnostic tests for JMML, an uncommon type of childhood leukemia that involves the movement of cancerous cells into tissues like the skin, lungs, and intestines. New diagnostic tests predict the likelihood of positive responses to intensive treatments and optimize patient outcomes in a disease with historically low survival rates.
PCRF's relentless pursuit of innovative breakthroughs has also contributed significantly to advances in acute myeloid leukemia (AML) treatments. Research supported by PCRF has led to the development of newer and more effective drugs, offering promising avenues to combat AML by targeting the overproduction of specific proteins.
0 notes
Text
Key Factors to Consider When Choosing a Clinical Research Company for Analytical Laboratory Services
In the world of pharmaceuticals, biotechnology, and medical devices, clinical research plays a pivotal role in bringing innovative treatments and therapies to market. Central to this process is the selection of a clinical research company that can provide comprehensive analytical laboratory services. This critical decision can significantly impact the success and efficiency of your research endeavors. In this article, we will delve into the key factors to consider when choosing a clinical research company for analytical laboratory services.
1. Expertise and Reputation
When evaluating clinical research companies, it's crucial to assess their expertise and reputation in the field. Look for companies with a proven track record of conducting successful clinical trials and providing high-quality analytical laboratory services. Consider factors such as the number of years they've been in operation, the types of projects they've worked on, and any industry awards or certifications they hold.
2. Regulatory Compliance
Compliance with regulatory standards is paramount in clinical research. Ensure that the company you choose adheres to the relevant regulatory guidelines, such as Good Laboratory Practices (GLP) and Good Clinical Practices (GCP). A company that consistently complies with these standards will help you avoid regulatory hurdles and ensure the integrity of your research data.
3. State-of-the-Art Facilities and Equipment
The quality of analytical laboratory services depends on the facilities and equipment available. Verify that the clinical research company possesses state-of-the-art laboratories equipped with cutting-edge instrumentation. Well-maintained and up-to-date equipment ensures accurate and reliable results in your research.
4. Specialization and Therapeutic Expertise
Different clinical research companies may specialize in various therapeutic areas, such as oncology, cardiology, or infectious diseases. Choose a company that aligns with your specific research needs. Their experience in your therapeutic area can bring valuable insights and efficiency to your project.
5. Capacity and Scalability
Consider the capacity and scalability of the clinical research company. Can they handle the volume of work required for your project? Scalability is essential, especially if your research project may expand in scope or require additional resources in the future. Ensure the company can adapt to your evolving needs.
6. Data Management and Reporting
Efficient data management and reporting are critical components of clinical research. Evaluate the company's data management systems and reporting capabilities. Clear and concise reporting can facilitate decision-making and regulatory submissions.
7. Geographic Location
Geographic location can impact logistical considerations, such as sample transportation and communication. Consider the location of the clinical research company in relation to your research sites and partners. Proximity can simplify collaboration and reduce potential delays.
8. Cost and Budget Alignment
While cost should not be the sole determining factor, it is essential to align your budget with the services offered by the clinical research company. Request detailed cost estimates and evaluate them in the context of the services, expertise, and quality provided. Balance cost considerations with the value and reliability of the services.
9. References and Client Feedback
Don't hesitate to request references from past clients or seek out client feedback and testimonials. Hearing about the experiences of others who have worked with the clinical research company can provide valuable insights into their strengths and weaknesses.
Conclusion
Choosing the right clinical research company for analytical laboratory services is a critical decision that can significantly impact the success of your research endeavors. By considering factors such as expertise, regulatory compliance, facilities, specialization, capacity, data management, location, cost, and references, you can make an informed choice that aligns with your research goals and ensures the highest quality outcomes. Take the time to thoroughly assess your options, as this decision is a crucial step toward advancing medical knowledge and improving patient care.
0 notes
Text
Dr. Gibran Khurshid - A Trailblazer in Ophthalmology and Ocular Oncology
Dr. Gibran Khurshid's journey into the field of ophthalmology began in Ireland, where he completed his residency in 2004. During this time, he also pursued a Master of Medical Sciences degree with honors from the National University of Ireland. His passion for learning and advancing his skills led him to undertake a Pediatric and Adult retina fellowship at Queen’s Medical Centre, Nottingham, United Kingdom, before acquiring another fellowship in Advanced Retina surgery and Ocular Oncology from the prestigious Royal Liverpool University and Clatterbridge Cancer Centre, United Kingdom. Despite his international training, Dr. Khurshid is not a Canadian citizen or permanent resident but a national of the United States.
In 2014, Dr. Khurshid joined the University of Florida (UF), shortly after his promotion to Clinical Associate Professor at the University of Texas Medical Branch. He began at UF as a Clinical Assistant Professor but quickly rose to the rank of Clinical Associate Professor by 2017. Throughout his tenure at UF, Dr. Khurshid has worked tirelessly to enhance his clinical, educational, and research portfolios. His contributions in these fields have impacted not only his patients and the Department of Ophthalmology at UF but the ophthalmology community as a whole through collaborative research efforts and worldwide philanthropy.
As a director of the retina and ocular oncology service, Dr. Gibran Khurshid brings a patient-focused approach to the team, emphasizing customer service and patient satisfaction without compromising clinical excellence. Under his supervision, the retina service at UF has tripled from a lone retina surgeon to a service boasting three full-time retina faculty with a fellowship program. This feat of growth aligns with Dr. Khurshid's belief in providing exemplary patient care as the service ranks as the top revenue-generating service in the department.
In addition to leading the retina service, Dr. Khurshid showcases the most diverse surgical skills in the department. His surgical and clinical prowess has earned him referrals from exceptionally challenging patients around the country, as detailed in section 8 of his clinical portfolio. Since his promotion, he has founded the internationally recognized “Center of Artificial Vision” at UF, focusing on restoring vision in blind patients.
Dr. Khurshid is one of only thirteen surgeons in the nation who implants the Argus® II device, also known as a “bionic eye.” This innovative surgical procedure has attracted surgeons from around the world to UF for training. Patients across the U.S. are also referred to UF to receive this groundbreaking device, further raising UF’s national prominence.
In recent years, Dr. Khurshid began a clinical trial for the implantation of the Artisan lens, a new type of lens placed inside the eye to treat rare lens disorders. This lens is the only choice for patients in which the eye loses its natural support for the lens. Dr. Khurshid is the sole surgeon performing this surgery in the region.
Currently, Dr. Khurshid is collaborating with the Applied Genetic Therapies Corporation to bring unique genetic therapy to treat blind patients with rare inherited retinal conditions at UF. These treatments, like the Argus® II device, involve complex surgical procedures designed to restore visual function and meet the needs of patients with rare, blinding conditions. Once these treatments are successfully implemented, they will offer hope to patients previously deemed irreversibly blind. For his achievements in artificial vision and genetic therapies, Dr. Khurshid received the “Best Doctors in America Award” in 2019 and 2020 by the American Health Council.
Beyond his work in artificial vision, Gibran Syed Khurshid established the ocular oncology service at UF. As the only ocular oncologist at UF Gainesville and Jacksonville, he ensures that his patients have access to the latest modalities in vision- and life-saving therapies. Moreover, Dr. Khurshid successfully undertook the task of arranging radiation plaque therapy for patients with intraocular tumors, which required extensive interdisciplinary coordination. He offers unique, state-of-the-art, targeted proton radiation therapy for eye cancers. In addition, he has incorporated gene expression profiling of the eye melanoma to offer customized treatments to patients and provide more predictive survival analysis.
Conventionally, ocular melanoma is treated with either removing the eye or external beam radiation. However, Dr. Khurshid liaises with providers in general oncology, radiation oncology, and genetics to develop an individualized treatment plan that best meets the patient's needs. He has developed UF into a hub for clinical trials and research in ocular oncology by developing reputable collaborations with academic centers worldwide. He is one of three surgeons in the Southeast to offer iodine radiation and brachytherapy treatment. Dr. Gibran Khurshid has also developed new surgical procedures to excise melanomas from the
A keen clinician, educator, researcher, innovator, and leader, Dr. Khurshid is dedicated to enhancing the care of his patients and paving a brighter future for the next generation of eye care professionals. His commitment to excellence in all aspects of patient care continues to be demonstrated through his tireless pursuit of clinical excellence, research collaboration, and innovation.
Dr. Khurshid continues to shape the landscape of ophthalmology through his research, teaching, and leadership. His exceptional skills have allowed him to take on challenging cases with remarkable success, making him one of the leading ophthalmologists in the country. His exemplary work has been recognized by numerous awards and honors, including the prestigious American Health Council’s “Best Doctors in America Award” for 2019 and 2020. His commitment to delivering the highest quality of patient care is evident in his achievements thus far, and will continue to lead the field of ophthalmology into a brighter future.
From his innovative research and clinical trials to his passion for excellent patient service, Dr. Gibran Khurshid's journey is one of inspiration and exemplary standards in ophthalmology. As he looks towards the future, there isno doubt that he will continue to provide outstanding care and innovation for the benefit of his patients. Dr. Khurshid's success is a testament to the high standards of patient service, excellence in clinical care, and dedication to innovation that he embodies. His unique contributions continue to be an inspiration to aspiring ophthalmologists and medical professionals alike.
0 notes
Text
Top Pharmaceutical Companies in India: RK Lifecare
The Amazing Journey of RK Lifecare, One of India's Top Pharmaceutical Companies
Introduction:
The pharmaceutical industry is essential to the healthcare sector because it creates and distributes medicines that save millions of lives worldwide. Numerous businesses have established themselves as major players in the market in India, a nation renowned for its growing pharmaceutical industry. RK Lifecare is one of these recognisable names. We'll look into RK Lifecare's history in this blog article and consider why it has been known as one of India's best pharmaceutical firms.
An overview in brief:
RK Lifecare, founded in 1998, has progressively expanded to become one of India's top pharmaceutical companies. The business has consistently shown its dedication to quality, innovation, and patient-centricity since its modest beginnings. The primary areas of focus for RK Lifecare include the manufacturing and distribution of a broad range of pharmaceutical goods, including prescription drugs, over-the-counter medicines, and various healthcare solutions.
Quality and Compliance:
RK Lifecare places a strong emphasis on quality and compliance, which is one of the keystones of its success. The business follows strict quality control procedures to guarantee that all of its products adhere to laws and standards around the world. RK Lifecare is devoted to upholding the highest standards of safety, effectiveness, and dependability in all of its pharmaceutical products. This commitment has resulted in the company's manufacturing facilities and quality management systems receiving numerous certifications and awards.
Research and Development:
RK Lifecare focuses a high priority on R&D in order to remain at the forefront of the pharmaceutical business. To spur innovation and create new medicines, the corporation makes large investments in cutting-edge technologies, specialized scientific knowledge, and infrastructure. RK Lifecare focuses on R&D in order to develop breakthrough therapeutics that solve unmet medical requirements, enhance patient outcomes, and progress healthcare as a whole.
Product Portfolio:
RK Lifecare has a wide range of products that address a variety of therapeutic areas, from oncology and infectious diseases to cardiovascular diseases and respiratory conditions. The company offers a wide variety of products, including generic medications, name-brand medications, biologics, nutraceuticals, and more. Patients all around India have access to inexpensive, high-quality healthcare solutions because of RK Lifecare's extensive product selection.
Excellence in Manufacturing:
RK Lifecare has cutting-edge manufacturing facilities that follow global standards and legal requirements. Modern procedures and technologies are installed in these facilities to guarantee the creation of pharmaceutical items that are both effective and safe. Because of its dedication to manufacturing excellence, the company has been able to continually meet the rising demand for its products while upholding the highest standards of quality.
Social Responsibility:
Beyond its business success, RK Lifecare understands its social responsibility and makes a concerted effort to advance societal well-being. The business participates in a range of philanthropic activities, including programmes for community improvement, education, and healthcare. RK Lifecare works to improve people's lives and communities by raising knowledge of and accessibility to healthcare.
Future Prognosis:
RK Lifecare's success story is a monument to the company's unwavering commitment to patient wellbeing, innovation, and quality. The company is well-positioned to broaden its product offerings, improve its production skills, and investigate new therapeutic fields as it keeps expanding. RK Lifecare is positioned to significantly impact the Indian pharmaceutical business in the next few years by remaining steadfast in its commitment to its fundamental values and striving for excellence.
Conclusion:
The incredible journey taken by RK Lifecare to become one of India's top pharmaceutical firms demonstrates the value of a constant dedication to quality, research, and patient-centricity. RK Lifecare is a leader in innovation and success in the Indian pharmaceutical industry thanks to its wide range of products, superior production practices, and emphasis on social responsibility. The organization will likely be a key player in determining the direction of healthcare in India and worldwide as it expands and changes.
#Pharmacy Manufacturers#Pharmaceutical#Pharmaceutical Production#Pharma Manufacturing Companies#Top Pharmaceutical Companies in India#Pharmaceutical Industry in India#Best Pharma Company in India#Pharma Exporters in India#Pharmaceutical Manufacturer#Medicine Manufacturing#Medicine Manufacturing Company#Pharma Exporter#Pharma Companies in India#Top 10 Pharma Companies in India#Pharmaceutical Companies#Pharma Company#Pharmaceutical Industry
1 note
·
View note
Text
Global Healthcare and Wellness Awards 2022: Meet the Winners
Hypedge Media awarded healthcare professionals and hospitals nationwide during the 2022 edition of the Global Healthcare and Wellness Awards 2022. This was held on the 19th of November 2022 at the WelcomHotel by ITC, Chennai.
The Chief Guest of the program was Padma Shri Dr. Vijay Kumar Shah, and the Guest of Honors was K. Pushpaleela (Ex-Minister, Women and Social Welfare Department ), Dr. R. Kannan (Chairman, Prime Indian Hospitals ), Prof. N. Balaji (Director & Trustee, Sri Narayani Hospital & Research Centre), Dr. C.J. Vetrievel (Director. - Be Well Hospitals), Sanjay Kumar Singh (Vice President, Sales Marketing
Rusan Pharma Ltd) and Gaurav Gautam (Founder of I CAN Foundation and CEO of Hypedge Media). They shared their wishes with all the selected awardees of GHWA 2022.
Global Healthcare and Wellness Awards are conferred on the outstanding / highest achievers in International Healthcare Industry. This most awaited global platform is bringing eminent healthcare experts together from the health world to understand the health revolution, market dynamics, the impact of digital technologies on the masses, and the future of health & healthcare in India. The platform would also recognize and felicitate massive efforts of various health initiatives, healthcare professionals, hospitals, institutions, and initiatives benefiting India through a technology-enabled healthcare ecosystem.
Here's the list of this Year's (2022) winners for the Global Healthcare and Wellness Awards:
Dr. Sangita Motiram Gavit
Excellence in Medical Education
Dr Narendra Singh
Excellence Award in Cardiology
Dr. Manasi Wakankar
Award for Leadership And Management in Healthcare
James Aruldas Silvai
Medical Innovation & Leadership Award
Dr. Ekta Shrivastava
Healthcare Icon of the Year
Dr. KVNN Santosh Murthy
Excellence in Diabetic Foot & Burns Management
Dr. RANJAN YADAV
Most Compassionate Doctor Award
Akula Laxmi
Award for Excellence in Research
Dr Deepti Mankad
Excellence Award in Mental Health & Counselling
Dr Sujit Kumar Satpathy
Healthcare Personality of the Year
Reshma Khan
Excellence in Medical Education
Alfred Goodwin
Lifetime Achievement Award
Dr.Arunkumar H
Best Diabetes and Diabetic Foot Care Specialist
Dr Deepika Goswami
Excellence in Medical Education
Dr.Nirmal Kumar Veeraragavan
Young Medical Entrepreneur of the year
Dr. Mankads' Homeoclinic
Best Homeopathy Centre
Arogyadeep Healthcare Pvt. Ltd
Excellence award in Acupuncture & Yoga Naturopathy
Dr Meghanad Meher
Excellence Award in General Medicine
Dr. Md Imteyaj
Most Compassionate Doctor Award
Dr. S.M. Shariq
Excellence Award in Orthopedics
Ryan Varghese
Medical Innovation & Leadership Award
Dr. Santosh Swathi Lakkoju
Healthcare Icon of the Year
Pradeep Kumar
Social Work Healthcare Award
Dharmendra Kumar Parihar
Excellence Award in Rural Healthcare
Dr. Harnoor Singh Pruthi
Excellence Award in Cardiology
ANUP KUMAR MISHRA
Excellence in Hospital Quality Management
Dr. Laila Beegum
Lifetime Achievement Award
Dr. Ajil Abdulla
Healthcare Entrepreneur of the Year
Dr.DEEPAK SINGH BAJETHA
Excellence Award in Physiotherapy
Dr Jayendra Narang
Excellence Award in Neurosurgery
TNB Aesthetic Secrets
Best Cosmetic Clinic
Dr Nancy Burat
Healthcare Icon of the Year
Dr Bahar Yawazy
Healthcare Icon of the Year
Dr. Chaitanya Seshu Babu. G
Healthcare Icon of the Year
Dr Capt G. Dhanan Jaya Rao
Life time achievement Award (Veterinary Surgery)
Dr Amanur Rahman Zaka
Most Compassionate Doctor Award
Srinivas Reddy
Best Hospital Administrator of the Year
Dr. Kumaragurubaran
Healthcare Icon of the Year
Scholar Overseas
Best Overseas Job Placement for Doctors and Nurses
Dr. Ayush Garg
Excellence Award in Oncology
Dr S.N. Lokesh Kumar
Excellence Award in Orthopedics
Mohamed Qutbuddin
Healthcare Entrepreneur of the Year
Dr. Supriya Munganda
Healthcare Entrepreneur of the Year
Dr Nibedita Sahoo
Healthcare Personality of the Year
Sourav Kumar Das
Healthcare Icon of the Year
Dr. Mantri Venkataswamy
Lifetime Achievement Award
Dr. B .C CHANDRA MOULI
Excellence Award in Cardiology
SRI CHANDRA SEKARA HOSPITAL
Best Hospital – Cardiology
PHYSKRAFT Superspeciality Physiotherapy Clinic
Best Physiotherapy Clinic
Manoj Shivaji Wakhare
Social Work Healthcare Award
Asha Mahila Milk Producer Company Limited
Leading Milk Producer Company
Shwetdhara Milk Producer Company Limited
Leading Milk Producer Company
SRI CHANDRA SEKARA HOSPITAL
COVID Response Award
Dr.Arunkumar H
Young Medical Entrepreneur of the year
Shri Vishnu Shri Hospital
Best Emerging Multi-Speciality Hospital (Madhya Pradesh )
Be Well Hospitals
Best Multi-Speciality Hospital
Dr Ashwani Mudgal
Excellence Award in Orthopedics
Dr.Hemapriya Jayapal
Medical Innovation & Leadership Award
KABIR HOSPITAL
Best Hospital for Wellness & Healthcare
Dr.Kavita Sudersanadas
Excellence in Nutrition and Dietetics Education
Dr. Karuna M S
Excellence Awards in Medical Nutrition Research and Education
Dr.Lesil George
Award for Best Psychologist
Dr. Raj Deokule
Award for the Best Diabetologist
Prof Dr N. Junior Sundresh
Excellence in Medical Education
Dr. Muneeb Ahmed M K
Excellency Award in Sexual Health
Dr Pradeep Thomas
Excellence Award in Accident and Emergency (A&E)
Dr. Sneha Shamkumar Londhe
Excellence Award in Obstetrics and Gynecology
Dr Mustafa Murtuza PT
Excellence Award in Physiotherapy
Dr Anu Jacob
Healthcare Personality of the Year
Dr. Kartikeswar Jena
Young Medical Entrepreneur of the year
PM Medical Centre
Best Hospital – Diabetology
Dr T Vadivel
Excellence Award in Regenerative Medicine
Dr.ARUN KRISHNA A K
Healthcare Entrepreneur of the Year'
Dr Raviram.S
Excellence Award in Laser Proctology
Dr.E.Kalaichezhian
Best Functional Rehab Specialist
Dr. B. Kalpana Kosalram
Healthcare Icon of the Year
Dr Kiran Kumar Varma K
Healthcare Icon of the Year
Yuva Dental Clinic
Best Dental Clinic
J. Benedicta Colleen
Social Work Healthcare Award
Dr.Indumathi.K.P
Excellence Award in Public Health Dentistry
Dr Renu Kumar Watwani
Excellence Award in Physiotherapy
Dr.Swarupa Rani K
Excellence Award in Radiology
Dr. Syed Ahmed Ali
Young Medical Entrepreneur of the year
Prof. N. Balaji
Healthcare Icon of the Year
Dr Farooq Ahmed Manur
Excellence Award in Accident and Emergency (A&E)
Dr Praveen H Jain
Excellence Award in Dentistry
Dr Jeswanthmal Khatod
Healthcare Entrepreneur of the Year
Dr. Ramesh Kumar
Healthcare Icon of the Year
Kosmoderma Healthcare Pvt. Ltd
Best Cosmetic Surgery Clinic
Dr. ANNAM VENKATA AJAY KUMAR
Excellence Award in Rural Healthcare
Dr.S.Senthilkumaran
Healthcare Icon of the Year
DR.K.S.ARUN PRAKASH
Excellence Award in Forensic Medicine
Dr. P. Senthil
Excellence Award in Physiotherapy
DR. C. MOHAMMED ALI
Most Compassionate Doctor Award
Riya Sara Mathew
Excellence Award in Nursing
SUBHOJIT MUKHERJEE
Healthcare Personality of the Year
Dr. Amit Mehta
Excellence in Homeopathy
PLUS ALPHA DIAGNOSTIC AND HEALTH CARE PVT LTD
Best Diagnostic & Imaging Centre
Dr. Sunil Babu K C
Excellence Award in Ayurveda
0 notes
Text
Final Assignment- Childhood Cancer: St. Jude Children’s Research Hospital
In this paper I will be talking about childhood cancer and how these children’s parents use social media to get the word out and try to understand this deadly disease. St. Jude Children’s Research Hospital is doing their best to stop childhood cancer.
Join St. Jude in the fight against childhood cancer. Donate today! No family receives a bill for treatment, travel, housing or food, because all a family should worry about is helping their child live. St. Jude has treated children from all 50 states ad from around the world. Treatments invented at St. Jude have helped push the overall childhood cancer survival rate from 20% to more than 80% since it opened more than 50 years ago. St. Jude use several social media platforms. There are many other hospitals who specialize in different types of childhood cancers, but I feel that St. Jude is the number one hospital when your child needs help. St. Jude uses social media as a great way to let parents know what they are doing to help these children.
Social media represent important resources for parents to engage with experts and peers over survivor-ship health. Facebook is the most commonly used social media platform. In a serve in January of this year, parents reported high levels of social media use, with 80% reporting daily use. Facebook was endorsed by 76% of its users, Twitter and Pinterest by 59%, Google+ 52%, and Instagram by 40%. Over 420,000 childhood cancer survivors (CCSs) are alive in the United States, and in 750 adults is a childhood cancer survivor.
Social media represent particularly promising platforms for the design and delivery of high-quality survivor-ship health information to parents of young CCSs. Social media are presently untapped resources for parents to engage with experts and peers over long-term survivor-ship health. Social media have emerged in the past decade as ubiquitous, innovative, and potentially powerful tools for health information sharing and health behavior change. Pediatric Brain Tumor Foundation has a social media toolkit. They say “social media is an easy way to raise awareness about the deadliest form of childhood cancer.
They have a Facebook, Twitter, and Instagram account. 13 children and teens are diagnosed each day with a brain tumor, more children die of brain tumors than any other cancer, and survivors often face lifelong side effects and years of tests and treatments. The PBTF’s research portfolio is paving the way for better treatments, increased survivor-ship and a higher quality of life for children and teens. The Pediatric Brain Tumor Foundation said “our Research Advisory Network, comprised of the top childhood brain tumor experts helps statically shape our research funding program for maximum impact”. St. Jude children’s hospital treats the toughest childhood cancers and pediatric diseases. St. Jude Children’s Research Hospital, founded in 1962, is a pediatric treatment and research facility focused on children’s catastrophic diseases, particularly leukemia and other cancers. The Cancer Center received its NCI designation in 1977 and was awarded status as a comprehensive cancer center by NCI in 2008. St. Jude has a staff of more than 4,000 including over 160 researches who are part of the Cancer Center. They are engaged in a broad spectrum of research including discover-oriented basic science research. The Cancer Center supports five major programs that are organized with the specific intent of translating basic science discoveries into creative therapies for children with cancer, while minimizing long-term side effects.
References
Ward E, DeSantis C, Robbins A, et al. Childhood and adolescent cancer statistics,2014. CA Cancer J Clin. 2014; 64:83-103
Hudson MM, Ness KK, Gurney JG, et al. Clinical ascertainment of health outcomes among adults treated for childhood cancer. JAMA. 2013; 309:2371-2381.
Oeffinger KC, Mertens AC, et al. Chronic health conditions in adult survivors of childhood cancer. N Engl. 2006; 355:1572-1582.
Phillips SM, Padgett LS, Leistering WM, et al. Survivors childhood cancer in the United States: prevalence and burden of morbidity. Cancer Epideniol Biomarkers Prev. 2015; 24:653-663.
Armstrong GT, Oeffinger KC, Chen, et al. Modifiable risk factor and major cardiac events among adult survivors of childhood cancer. J Clin Oncol. 2013; 31:3673-3680.
Slater ME, Steinberger J, Ross JA, et al. Physical activity, fitness, and cardiometabolic risk factors in adult survivors of childhood cancer with a history of hematopoietic cell transplantation. Biol Marrow Transplant, 2015; 21:1278-12183.
Children’s Oncology Group. Long-Term Follow-Up Guidelines for Survivors of Childhood, Adolescent, and Young Adult Cancer. Monrovia, CA: Children’s Oncology Group; 2013.
Ford J, Barnett M, Work R. Health behaviors of childhood cancer survivors. Children (Basel) 2014; 1:355-373.
Tonorezos ES, Sharp L. Health promotion for adolescent leukemia survivors. Pediatric Blood Cancer. 2013; 60:893-894.
Elliot DL, Lindemulder SJ, Goldberg L, et al. Health promotion for adolescent childhood leukemia survivors and ehealth. Pediatric Blood Cancer. 2013; 60:905-910
11. https://www.stjude.org/give.html?sc_dcm=236375153&sc_cid=kwp70571&source_code=IIQ181010008&ef_id=CjwKCAiAyfvhBRBsEiwAe2t_i_wnE9tmqavy7pK_DBhUUzDPNmL-xrVZbHcHraPsXcIwtcWvVIdFmxoCU-kQAvD_BwE:G:s&s_kwcid=AL!4519!3!322242235581!e!!g!!st%20judes%20charity%20rating
@necsocialmedia
2 notes
·
View notes
Text
Importance of Molecular Quality Controls in Healthcare
The Molecular Quality Controls Market size was estimated at USD 0.1 billion in 2023 and is expected to reach USD 0.16 billion by 2031 with a growing CAGR of 6.7% during the forecast period of 2024-2031.The Molecular Quality Controls Market is a dynamic sector within diagnostic testing, pivotal in ensuring the accuracy and reliability of molecular assays. As advancements in genomic and proteomic technologies continue to accelerate, the demand for precise quality control measures has surged.
These controls not only validate the performance of diagnostic tests but also mitigate risks associated with false results, thereby enhancing patient care outcomes. With a diverse range of applications spanning infectious diseases, oncology, and genetic disorders, the market is characterized by a steady evolution of innovative control solutions tailored to meet stringent regulatory requirements worldwide. Key players are increasingly focusing on developing customizable, high-quality controls that mirror clinical samples, thereby addressing the complexities of modern molecular diagnostics with unparalleled precision and reliability.
The most recent Molecular Quality Controls Market analysis examines worldwide and regional market estimations and predictions for all research segments. As the report includes a comprehensive market assessment across significant geographies such as North America, Europe, Asia Pacific, the Middle East, Latin America, and the Rest of the World, the report is useful for existing companies, prospective entrants, and potential investors. The market data was compiled using both primary and secondary sources. Other aspects of the industry have been explored, such as the supply chain, downstream buyers, and sourcing strategy, in order to offer a complete and comprehensive picture of the market.
Get Sample Copy Of This Report @ https://www.snsinsider.com/sample-request/3658
Market Segmentation
By Product
Independent Controls
Instrument-Specific Controls
By Analyte Type
Single-Analyte Controls
Multi-Analyte Controls
By Application
Infectious Diseases
Oncology
Genetic Testing
Other Applications
By End User
Clinical Laboratories
Hospitals
IVD Manufacturers and Contract Research Organizations
Academic and Research Institutes
Other End Users
Competitive Outlook
In the report's conclusion, there is a descriptive section that covers the feasibility of new projects that may succeed in the global market in the near future, as well as the global market's overall scope in terms of investment feasibility in various segments of the Molecular Quality Controls Market industry. For each of the market's top competitors, the research includes current business profiles, gross margins, selling price, sales income, sales volume, product specifications with images, and contact information.
Key Highlights of the Molecular Quality Controls Market Report
COVID-19's impact on the target market's company operations and revenue generation.
Accurate forecasting of future trends, as well as visible shifts in customer behavior.
A thorough examination of the factors that will drive market expansion in the coming years.
An in-depth examination of the market's competitive landscape, as well as detailed information on individual providers.
About Us
SNS Insider is a market research and insights firm that has won several awards and earned a solid reputation for service and strategy. We are a strategic partner who can assist you in reframing issues and generating answers to the trickiest business difficulties. For greater consumer insight and client experiences, we leverage the power of experience and people.
When you employ our services, you will collaborate with qualified and experienced staff. We believe it is crucial to collaborate with our clients to ensure that each project is customized to meet their demands. Nobody knows your customers or community better than you do. Therefore, our team needs to ask the correct questions that appeal to your audience in order to collect the best information.
Related Reports
Flash Chromatography Market Size
Cystic Fibrosis Market Size
Cancer Biopsy Market Size
Glaucoma Therapeutics Market Size
Genomics Services Market Size
0 notes
Text
Global Haematology and Flow Cytometry Market
Global Haematology and Flow Cytometry Market is expected to reach $XX Mn by 2026 from $XX Mn in 2019, at a CAGR of 8.5% during forecast period.
Global Haematology and Flow Cytometry Market Overview:
Hematology is a medical specialty that deals with the study and treatment of blood. This is concerned with the diagnosis, study, treatment, and prevention of blood diseases. Flow cytometry is an analytical tool that is used in the measurement and analysis of several physical characteristics of cells or particles suspended in a fluid using a laser beam. The method helps to subclassify cell types to decide on the best treatment plan.
Global Haematology and Flow Cytometry Market Dynamics:
Rising global incidence and prevalence of chronic diseases like blood cancer is the major driving factor for the market growth. According to the National Cancer Institute in 2018, it was being estimated that 60,300 new leukemia cases are diagnosed and the deaths are around 24,470 cases in the United States. The increasing number of HIV cases globally is an important driver for the flow cytometry market. This is because the flow cytometry technique has its direct application in HIV diagnosis. According To UNAIDS in 2017, 31.1-43.9 million people globally are living with HIV by out of which 1.8 million are newly affected with HIV. Flow cytometry uses light scattering to determine the identity of cells. Increasing adoption of flow cytometry techniques in research and academia and growing initiatives in the field of immunology and Immuno-oncology researches are expected to propel the growth of the global flow cytometry market. Growth in stem cell research and the development of high-throughput flow cytometry technologies are likely to add new opportunities for this market in the coming years. Increasing regulatory approval and the introduction of technologically advanced flow cytometry solutions are expected to facilitate market growth over the forecast period. For instance, in June 2020, Sysmex Corporation launched the XF-1600 flow cytometer for laboratories, in North America. A significant restraint on the flow cytometry market is the availability of cheaper and better alternatives. ELISA (enzyme-linked immunosorbent assay) and radioimmunoassay are two of these alternatives. Although flow cytometry, ELISA, and radioimmunoassay are all methods for detecting "problem cells" in a community of cells, ELISA and radioimmunoassay are less expensive and easier to use. Along with this, the dearth of skilled technicians for managing such advanced technology is expected to restrain the market growth. The report has profiled twenty key players in the market from different regions. However, report has considered all market leaders, followers and new entrants with investors while analyzing the market and estimation the size of the same. Increasing R&D activities in each region are different and focus is given on the regional impact on the cost, availability of advanced technology are analyzed and report has come up with recommendations for future hot spot in APAC region.
Global Haematology and Flow Cytometry Market Segment Analysis:
The Global Haematology and Flow Cytometry Market is segment on the basis of Product, Technology and End-Users. Based on Product, the flow cytometry instruments segment is expected to dominate the global market. The segment is further classified into cell analyzers and cell sorters. It held a market share of 25% in 2020. This high share is attributed to new advancements in technology and the introduction of novel cytometers by key players. The high price of these instruments is also contributing toward the high revenue generation in this segment. Along with this, reagents and consumables also held a prominent share in 2020. Owing to their increased adoption in diagnostics and research the segment is expected to register lucrative growth over the forecast period. The large share of this segment is mainly attributed to the growing research activities to develop and prove the efficacy of various assays and kits, and the commercialization of high-quality and application-specific consumables, reagents, and assays. Based on technology, the cell-based flow cytometry segment held the largest market share of 76% in 2020. The highest share is due to an increase in demand for early diagnosis and increased understanding of the related benefits of cell-based assays. In addition, advances in cell-based assay technology, such as innovations in tools, labels, affinity reagents, software, and algorithms, are expected to accelerate adoption in the coming years. To know about the Research Methodology :- Request Free Sample Report
Global Haematology and Flow Cytometry Market Regional Insights:
North America dominated the global market in 2020. The region dominated the global market in 2020 by holding a market share of 39.1%. This dominance is attributed due to the United States' high healthcare spending, well-developed healthcare system, and widespread adoption of technologically advanced flow cytometry solutions. In addition, the established pharmaceutical industry, as well as extensive research activities by research universities and pharmaceutical companies has generated huge demand for flow cytometry solutions for research universities and pharmaceutical companies have created a huge demand for flow cytometry solutions for research needs. APAC region is projected to exhibit highest CAGR during forecast period. This high growth can be attributed to the extensive growth in the pharmaceutical and biotechnology industries of emerging economies, such as China and India. The lucrative growth exhibited by this region is also an outcome of continuous government support for the establishment of the pharmaceutical industry in emerging countries. The report also helps in understanding Global Haematology and Flow Cytometrys Market dynamics, structure by analyzing the market segments and project the Global Haematology and Flow Cytometrys Market size. Clear representation of competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence in the Global Haematology and Flow Cytometrys Market make the report investor’s guide.
Global Haematology and Flow Cytometry Market, key developments:
• In September 2018, the U.S. FDA awarded a grant of ~$18 million over a period of four years for 12 new clinical trials. These clinical trials are aimed at developing products for patients with rare diseases (including primary sclerosing cholangitis, stargardt disease, Cushing disease, acute myeloid leukemia, and graft versus host disease, among others). • In March 2017, Cytek Biosciences Inc., a manufacturer and supplier of flow cytometry products and services launched its DxP Athena flow cytometry system. The system is compact, powerful, easy-to-use cell analyzer that are typically only found in conventional instruments that come with a much higher price tag. The DxP Athena makes the benefits of flow cytometry which are more readily available to larger number of researchers by its compact size. • In 2016, the Global Clinical Trials Fund (U.K.) launched a dedicated fund with an upper limit of $662,185 to support clinical trials across the world related to the testing of new experimental drugs and existing drugs developed for dementia.
Global Haematology and Flow Cytometry Market Scope: Inquire before buying
Global Haematology and Flow Cytometry Market, by Region:
• North America • Europe • South America • MEA • APAC
Global Haematology and Flow Cytometry Market, Key players:
• Becton, Dickinson and Company • Beckman Coulter, Inc. • Bio-Rad Laboratories, Inc. • Thermo Fisher Scientific, Inc. • Merck KGaA • Sysmex Partec GmbH • Luminex Corporation • Miltenyi Biotec GmbH • Sony Biotechnology • Abbott • Agilent Technologies • CellaVision • Horiba • Nihon Kohden • Ortho-Clinical Diagnostics • Roche • Siemens Healthineers • Sysmex • Miltenyi Biotec • Apogee Flow Systems Ltd.
0 notes